Novartis Pharma Schweiz AG - Certican 0.25 mg, Tabletten | | 56238 | | 03 | | Certican 0.25 mg | | Tabletten | | L04AA18 | | Everolimus | | 21.04.2005 | | |
| Composition | everolimusum 0.25 mg, lactosum monohydricum 2.23 mg, hypromellosum, magnesii stearas, crospovidonum, lactosum 51.1 mg, E 321, pro compresso. | Packungsbestandteile | | Tablets | | | Active Agent | Dose |
---|
Everolimus | 0.25 mg |
| BAG: Active Agent | Dose |
---|
Everolimus | 0.25 mg |
| | Inactive agents | Dose |
---|
Crospovidonum | | E 321 | | Hypromellosum | | Lactosum | 51.1 mg | Lactose Monohydrate | 2.23 mg | Magnesii Stearas | | Pro Compresso | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
005 | 60 Tablet(s) | 145.64 | 174.80 | B | SL | Yes |
|
|